Linde plc (EU)

  • WKN: A2DSYC
  • ISIN: IE00BZ12WP82
  • Land: Irland

Nachricht vom 23.10.2019 | 12:00

Linde acquires minority stake in ITM Power and agrees joint venture

DGAP-News: Linde plc / Key word(s): Investment/Joint Venture

23.10.2019 / 12:00
The issuer is solely responsible for the content of this announcement.


Linde acquires minority stake in ITM Power and agrees joint venture

Guildford, UK, October 23, 2019 - Linde (NYSE: LIN; FWB: LIN) announced today that it has acquired a minority stake in ITM Power plc (AIM: ITM), a British manufacturer of polymer electrolyte membrane (PEM) electrolyzers for the electro-chemical splitting of water into hydrogen and oxygen.

The transaction, which was completed on October 22, provides Linde with a strategic investment in a world leading manufacturer of integrated hydrogen energy solutions.

In addition to its investment, Linde will form a joint venture with ITM Power to implement projects based on ITM Power's technology. By bringing together ITM Power's expertise in PEM electrolysis and Linde's leading engineering procurement and construction experience, the joint venture will target large-scale industrial users, particularly in the metals and glass, electronics, refinery, chemistry and steel industries. In addition to opening new commercial opportunities, the joint venture is expected to create capacity to deliver a higher volume of projects, shorten lead times, improve execution and reduce costs.

"This investment reflects Linde's ongoing focus to deliver sustainable solutions while helping to make our customers more successful", said Dr Christian Bruch, Executive Vice President and CEO Linde Engineering. "The joint venture is an excellent opportunity to combine Linde's world-class engineering capabilities with ITM Power's electrolysis technology."

"The investment from Linde cements the relationship between us and provides ITM Power with a world-leading partner that brings deep expertise in engineering, procurement and construction plus a global customer base", said Dr Graham Cooley, CEO, ITM Power.

About Linde
Linde is a leading industrial gases and engineering company with 2018 pro forma sales of USD 28 billion (EUR 24 billion). The company employs approximately 80,000 people globally and serves customers in more than 100 countries worldwide. Linde delivers innovative and sustainable solutions to its customers and creates long-term value for all stakeholders. The company is making our world more productive by providing products, technologies and services that help customers improve their economic and environmental performance in a connected world.

For more information about the company, please visit www.linde.com

Contacts:  
Investor Relations
Juan Pelaez
Phone: +1 203 837 2213
Email: juan.pelaez@linde.com
Media Relations
Anna Davies
Phone: +44 1483 244705
Email: anna.davies@linde.com


23.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Anleihe im Fokus

Deutsche Rohstoff
"Anleihe - Jetzt zeichnen!"

- Emissionsvolumen: bis zu 100 Mio. EUR
- Zeichnungsfrist: 11.11. bis 04.12.2019
- ISIN: DE000A2YN3Q8 / WKN: A2YN3Q
- Börsenesegment: Börse Frankfurt, Open Market (Quotation Board)
- Stückelung / Emissionspreis: 1.000 EUR/ 100%
- Zinssatz (Kupon): 5,25 %
- Laufzeit: 5 Jahre
- Fälligkeit: 5 Jahre / 6.12.2024 (vorbehaltliche vorzeitige Rückzahlung gemäß Anleihebedingungen)
- Zinszahlung: Angebot an Inhaber der 5,625 % Schuldverschreibung 2016/2021 (WKN A2AA05, ISIN DE000A2AA055) diese in die neue Anleihe zu tauschen
- Umtauschfrist: 11.11.2019 – 29.11.2019 (18.00 Uhr)

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Linde plc: Linde Reports Third-Quarter 2019 Results (Earnings Release Tables attached) (news with additional features)

12. November 2019, 12:01

Aktueller Webcast

EQS Group AG

Conference Call zu den Neunmonatszahlen 2019

15. November 2019

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

13. November 2019